Cargando…

Experimental Models of Ischemic Lung Damage for the Study of Therapeutic Reconditioning During Ex Vivo Lung Perfusion

BACKGROUND. Ex vivo lung perfusion (EVLP) may allow therapeutic reconditioning of damaged lung grafts before transplantation. This study aimed to develop relevant rat models of lung damage to study EVLP therapeutic reconditioning for possible translational applications. METHODS. Lungs from 31 rats w...

Descripción completa

Detalles Bibliográficos
Autores principales: Parapanov, Roumen, Wang, Xingyu, Wang, Yabo, Debonneville, Anne, Lugrin, Jérôme, Liaudet, Lucas, Krueger, Thorsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191352/
https://www.ncbi.nlm.nih.gov/pubmed/35702630
http://dx.doi.org/10.1097/TXD.0000000000001337
_version_ 1784725992957280256
author Parapanov, Roumen
Wang, Xingyu
Wang, Yabo
Debonneville, Anne
Lugrin, Jérôme
Liaudet, Lucas
Krueger, Thorsten
author_facet Parapanov, Roumen
Wang, Xingyu
Wang, Yabo
Debonneville, Anne
Lugrin, Jérôme
Liaudet, Lucas
Krueger, Thorsten
author_sort Parapanov, Roumen
collection PubMed
description BACKGROUND. Ex vivo lung perfusion (EVLP) may allow therapeutic reconditioning of damaged lung grafts before transplantation. This study aimed to develop relevant rat models of lung damage to study EVLP therapeutic reconditioning for possible translational applications. METHODS. Lungs from 31 rats were exposed to cold ischemia (CI) or warm ischemia (WI), inflated at various oxygen fractions (FiO(2)), followed by 3 h EVLP. Five groups were studied as follow: (1) C21 (control): 3 h CI (FiO(2) 0.21); (2) C50: 3 h CI (FiO(2) 0.5); (3) W21: 1 h WI, followed by 2 h CI (FiO(2) 0.21); (4) W50: 1 h WI, followed by 2 h CI (FiO(2) 0.5); and (5) W2h: 2 h WI, followed by 1 h CI (FiO(2) 0.21). Following 3 h EVLP, we measured static pulmonary compliance (SPC), pulmonary vascular resistance, lung weight gain (edema), oxygenation capacity (differential partial pressure of oxygen), and protein carbonyls in lung tissue (oxidative stress), as well as lactate dehydrogenase (LDH, lung injury), nitrotyrosine (nitro-oxidative stress), interleukin-6 (IL-6, inflammation), and proteins (permeability edema) in bronchoalveolar lavage (BAL). Perivascular edema was quantified by histology. RESULTS. No significant alterations were noted in C21 and C50 groups. W21 and W50 groups had reduced SPC and disclosed increased weight gain, BAL proteins, nitrotyrosine, and LDH. These changes were more severe in the W50 group, which also displayed greater oxidative stress. In contrast, both W21 and W50 showed comparable perivascular edema and BAL IL-6. In comparison with the other WI groups, W2h showed major weight gain, perivascular edema, SPC reduction, drop of differential partial pressure of oxygen, and massive increases of BAL LDH and proteins but comparable increase of IL-6 and biomarkers of oxidative stress. CONCLUSIONS. These models of lung damage of increasing severity might be helpful to evaluate new strategies for EVLP therapeutic reconditioning. A model combining 1 h WI and inflation at FiO(2) of 0.5 seems best suited for this purpose by reproducing major alterations of clinical lung ischemia-reperfusion injury.
format Online
Article
Text
id pubmed-9191352
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-91913522022-06-13 Experimental Models of Ischemic Lung Damage for the Study of Therapeutic Reconditioning During Ex Vivo Lung Perfusion Parapanov, Roumen Wang, Xingyu Wang, Yabo Debonneville, Anne Lugrin, Jérôme Liaudet, Lucas Krueger, Thorsten Transplant Direct Basic Science BACKGROUND. Ex vivo lung perfusion (EVLP) may allow therapeutic reconditioning of damaged lung grafts before transplantation. This study aimed to develop relevant rat models of lung damage to study EVLP therapeutic reconditioning for possible translational applications. METHODS. Lungs from 31 rats were exposed to cold ischemia (CI) or warm ischemia (WI), inflated at various oxygen fractions (FiO(2)), followed by 3 h EVLP. Five groups were studied as follow: (1) C21 (control): 3 h CI (FiO(2) 0.21); (2) C50: 3 h CI (FiO(2) 0.5); (3) W21: 1 h WI, followed by 2 h CI (FiO(2) 0.21); (4) W50: 1 h WI, followed by 2 h CI (FiO(2) 0.5); and (5) W2h: 2 h WI, followed by 1 h CI (FiO(2) 0.21). Following 3 h EVLP, we measured static pulmonary compliance (SPC), pulmonary vascular resistance, lung weight gain (edema), oxygenation capacity (differential partial pressure of oxygen), and protein carbonyls in lung tissue (oxidative stress), as well as lactate dehydrogenase (LDH, lung injury), nitrotyrosine (nitro-oxidative stress), interleukin-6 (IL-6, inflammation), and proteins (permeability edema) in bronchoalveolar lavage (BAL). Perivascular edema was quantified by histology. RESULTS. No significant alterations were noted in C21 and C50 groups. W21 and W50 groups had reduced SPC and disclosed increased weight gain, BAL proteins, nitrotyrosine, and LDH. These changes were more severe in the W50 group, which also displayed greater oxidative stress. In contrast, both W21 and W50 showed comparable perivascular edema and BAL IL-6. In comparison with the other WI groups, W2h showed major weight gain, perivascular edema, SPC reduction, drop of differential partial pressure of oxygen, and massive increases of BAL LDH and proteins but comparable increase of IL-6 and biomarkers of oxidative stress. CONCLUSIONS. These models of lung damage of increasing severity might be helpful to evaluate new strategies for EVLP therapeutic reconditioning. A model combining 1 h WI and inflation at FiO(2) of 0.5 seems best suited for this purpose by reproducing major alterations of clinical lung ischemia-reperfusion injury. Lippincott Williams & Wilkins 2022-06-10 /pmc/articles/PMC9191352/ /pubmed/35702630 http://dx.doi.org/10.1097/TXD.0000000000001337 Text en Copyright © 2022 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Basic Science
Parapanov, Roumen
Wang, Xingyu
Wang, Yabo
Debonneville, Anne
Lugrin, Jérôme
Liaudet, Lucas
Krueger, Thorsten
Experimental Models of Ischemic Lung Damage for the Study of Therapeutic Reconditioning During Ex Vivo Lung Perfusion
title Experimental Models of Ischemic Lung Damage for the Study of Therapeutic Reconditioning During Ex Vivo Lung Perfusion
title_full Experimental Models of Ischemic Lung Damage for the Study of Therapeutic Reconditioning During Ex Vivo Lung Perfusion
title_fullStr Experimental Models of Ischemic Lung Damage for the Study of Therapeutic Reconditioning During Ex Vivo Lung Perfusion
title_full_unstemmed Experimental Models of Ischemic Lung Damage for the Study of Therapeutic Reconditioning During Ex Vivo Lung Perfusion
title_short Experimental Models of Ischemic Lung Damage for the Study of Therapeutic Reconditioning During Ex Vivo Lung Perfusion
title_sort experimental models of ischemic lung damage for the study of therapeutic reconditioning during ex vivo lung perfusion
topic Basic Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191352/
https://www.ncbi.nlm.nih.gov/pubmed/35702630
http://dx.doi.org/10.1097/TXD.0000000000001337
work_keys_str_mv AT parapanovroumen experimentalmodelsofischemiclungdamageforthestudyoftherapeuticreconditioningduringexvivolungperfusion
AT wangxingyu experimentalmodelsofischemiclungdamageforthestudyoftherapeuticreconditioningduringexvivolungperfusion
AT wangyabo experimentalmodelsofischemiclungdamageforthestudyoftherapeuticreconditioningduringexvivolungperfusion
AT debonnevilleanne experimentalmodelsofischemiclungdamageforthestudyoftherapeuticreconditioningduringexvivolungperfusion
AT lugrinjerome experimentalmodelsofischemiclungdamageforthestudyoftherapeuticreconditioningduringexvivolungperfusion
AT liaudetlucas experimentalmodelsofischemiclungdamageforthestudyoftherapeuticreconditioningduringexvivolungperfusion
AT kruegerthorsten experimentalmodelsofischemiclungdamageforthestudyoftherapeuticreconditioningduringexvivolungperfusion